Inventor · disambiguated record
Kimberly Ann Tipton
Also filed as: TIPTON KIMBERLY · TIPTON KIMBERLY ANN
8 granted patents·4 pending applications·72 citations·filing 2016–2025
84Inventor score
Files withCYTOMX THERAPEUTICS INC5VERTEX PHARMA3BRISTOL MYERS SQUIBB CO2IMMUNOGEN INC1PH PHARMA CO LTD1
Top patents by PatentIndex Score
12 records- 0198US10179817B2Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Jan 15, 2019·36 cites·58 claims
- 0294US11267896B2Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Mar 8, 2022·10 cites·34 claims
- 0392US10513558B2Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Dec 24, 2019·23 cites·77 claims
- 0486US12441799B2Activatable anti-CTLA-4 antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 14, 2025·1 cites·14 claims
- 0580US11117968B2Activatable anti-CTLA-4 antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 14, 2021·2 cites·20 claims
- 0674US12331334B2Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·0 cites·65 claims
- 0772US2022306759A1Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0868US10815246B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2019·Granted Oct 27, 2020·0 cites·17 claims
- 0966US2025263683A1Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 1057US2021179713A1Anti-pd-1 antibodies, activatable anti-pd-1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1152US11613744B2Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2020·Granted Mar 28, 2023·0 cites·77 claims
- 1250US2021403594A1Epcam antibodies, activatable antibodies, and immunoconjugates, and uses thereofIMMUNOGEN INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →